Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation identifies a subpopulation of glioblastoma patients with more favorable prognosis and predicts a benefit from alkylating agent chemotherapy (CT). Little is known about its prevalence and clinical significance in older glioblastoma pa...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2012
|
| In: |
International journal of cancer
Year: 2012, Volume: 131, Issue: 6, Pages: 1342-1350 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.27385 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1002/ijc.27385 Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.27385 
|
| Author Notes: | Guido Reifenberger, Bettina Hentschel, Jörg Felsberg, Gabriele Schackert, Matthias Simon, Oliver Schnell, Manfred Westphal, Wolfgang Wick, Torsten Pietsch, Markus Loeffler and Michael Weller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1572693177 | ||
| 003 | DE-627 | ||
| 005 | 20220814132421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180504s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ijc.27385 |2 doi | |
| 035 | |a (DE-627)1572693177 | ||
| 035 | |a (DE-576)502693177 | ||
| 035 | |a (DE-599)BSZ502693177 | ||
| 035 | |a (OCoLC)1341008862 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Reifenberger, Guido |e VerfasserIn |0 (DE-588)1082574740 |0 (DE-627)847675068 |0 (DE-576)455525382 |4 aut | |
| 245 | 1 | 0 | |a Predictive impact of MGMT promoter methylation in glioblastoma of the elderly |c Guido Reifenberger, Bettina Hentschel, Jörg Felsberg, Gabriele Schackert, Matthias Simon, Oliver Schnell, Manfred Westphal, Wolfgang Wick, Torsten Pietsch, Markus Loeffler and Michael Weller |
| 264 | 1 | |c 2012 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First published: 03 December 2011 | ||
| 500 | |a Gesehen am 04.05.2018 | ||
| 520 | |a O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation identifies a subpopulation of glioblastoma patients with more favorable prognosis and predicts a benefit from alkylating agent chemotherapy (CT). Little is known about its prevalence and clinical significance in older glioblastoma patients. We studied 233 glioblastoma patients aged 70 years or more (144 males, 89 females, median age: 74 years, range: 70.0-86.6 years), who were prospectively enrolled in the German Glioma Network, for MGMT promoter methylation by methylation-specific PCR (MSP) in all patients and DNA pyrosequencing in 166 patients. MGMT data were correlated with patient outcome. Median progression-free survival (PFS) was 4.8 months (95% CI: 4.3-5.3) and median overall survival (OS) was 7.7 months (95% CI: 6.3-9.0). MGMT promoter methylation was detected by MSP in 134 patients (57.5%). For the whole cohort, PFS was 5.2 versus 4.7 months (p = 0.207) and OS was 8.4 versus 6.4 months (p = 0.031) in patients with versus without MGMT promoter methylation. Patients with MGMT methylated tumors had longer PFS when treated with radiotherapy (RT) plus CT or CT alone compared to patients treated with RT alone. Patients with MGMT unmethylated tumors appeared to derive no survival benefit from CT, regardless of whether given at diagnosis together with RT or as a salvage treatment. Patients treated with RT plus CT or CT alone demonstrated longer OS when pyrosequencing revealed >25% MGMT methylated alleles. Taken together, MGMT promoter methylation may be a useful biomarker to stratify elderly glioblastoma patients for treatment with versus without alkylating agent CT. | ||
| 650 | 4 | |a age | |
| 650 | 4 | |a glioblastoma | |
| 650 | 4 | |a O6-methylguanine-DNA-methyltransferase | |
| 650 | 4 | |a predictive marker | |
| 650 | 4 | |a prognosis | |
| 650 | 4 | |a promoter methylation | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d Bognor Regis : Wiley-Liss, 1966 |g 131(2012), 6, Seite 1342-1350 |h Online-Ressource |w (DE-627)269532781 |w (DE-600)1474822-8 |w (DE-576)079876129 |x 1097-0215 |7 nnas |a Predictive impact of MGMT promoter methylation in glioblastoma of the elderly |
| 773 | 1 | 8 | |g volume:131 |g year:2012 |g number:6 |g pages:1342-1350 |g extent:9 |a Predictive impact of MGMT promoter methylation in glioblastoma of the elderly |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ijc.27385 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.27385 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180504 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 8 | ||
| 999 | |a KXP-PPN1572693177 |e 3007967473 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Guido Reifenberger, Bettina Hentschel, Jörg Felsberg, Gabriele Schackert, Matthias Simon, Oliver Schnell, Manfred Westphal, Wolfgang Wick, Torsten Pietsch, Markus Loeffler and Michael Weller"]},"id":{"doi":["10.1002/ijc.27385"],"eki":["1572693177"]},"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"relHost":[{"id":{"doi":["10.1002/(ISSN)1097-0215"],"zdb":["1474822-8"],"issn":["1097-0215"],"eki":["269532781"]},"part":{"year":"2012","volume":"131","pages":"1342-1350","text":"131(2012), 6, Seite 1342-1350","extent":"9","issue":"6"},"pubHistory":["1.1966 -"],"titleAlt":[{"title":"Predictive oncology"}],"corporate":[{"display":"International Union against Cancer","role":"isb"}],"disp":"Predictive impact of MGMT promoter methylation in glioblastoma of the elderlyInternational journal of cancer","titleTranslated":[{"translated":"Journal international du cancer"}],"recId":"269532781","physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer","title":"International journal of cancer"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"origin":[{"publisher":"Wiley-Liss","dateIssuedKey":"1966","dateIssuedDisp":"1966-","publisherPlace":"Bognor Regis"}]}],"person":[{"display":"Reifenberger, Guido","role":"aut","given":"Guido","family":"Reifenberger"},{"role":"aut","given":"Wolfgang","family":"Wick","display":"Wick, Wolfgang"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["First published: 03 December 2011","Gesehen am 04.05.2018"],"title":[{"title":"Predictive impact of MGMT promoter methylation in glioblastoma of the elderly","title_sort":"Predictive impact of MGMT promoter methylation in glioblastoma of the elderly"}],"physDesc":[{"extent":"9 S."}],"recId":"1572693177"} | ||
| SRT | |a REIFENBERGPREDICTIVE2012 | ||